FDA Clinical Trial Material Labeling
Question: We are importing fully released, CBER-approved commercial lots to use in Clinical Trials. Are approved vaccines used in clinical trials considered to be investigation new drugs? Do we need to meet the labeling requirements of 312.6 (“Caution: For clinical trial use only”) even though this is a fully released, CBER-approved commercial lots because the […]